Transgenomic, Inc. Announces Executive Changes
Published: Sep 30, 2013
Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that Paul Kinnon has been named President, Chief Executive Officer and a Director, replacing Craig J. Tuttle, effective today.
Help employers find you! Check out all the jobs and post your resume.